ARCHIVES

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

This article is from The Cancer Letter archive.

Vol. 33 No. 20 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

FDA Committee to Discuss Policy On Combinations

January 7, 1977

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012